Sugi's Profit Plummets 68% in Fiscal Q1
Sugi's (TYO:7649) profit attributable to owners of the parent plunged 68% to 6.9 billion yen for the fiscal first quarter from 21.2 billion yen a year earlier. The pharmaceutical group's basic earnings per share declined to 38.14 yen from 117.28 yen a year ago, according to a Tokyo bourse filing on Thursday. Net sales jumped over 10% to 270.2 billion yen for the three months ended May 31 from 245.5 billion yen in the prior-year period. For the fiscal year ending Feb. 28, 2027, the company expects attributable profit of 32.8 billion yen, basic EPS of 181.24 yen and net sales of 1.092 trillion yen. Sugi plans to pay interim and year-end dividends of 15 yen and 10 yen per share, respectively, for the current year, which is lower than the total 35 yen per share paid in the year-ago period.
Sugi's (TYO:7649) profit attributable to owners of the parent plunged 68% to 6.9 billion yen for the fiscal first quarter from 21.2 billion yen a year earlier.
The pharmaceutical group's basic earnings per share declined to 38.14 yen from 117.28 yen a year ago, according to a Tokyo bourse filing on Thursday.
Net sales jumped over 10% to 270.2 billion yen for the three months ended May 31 from 245.5 billion yen in the prior-year period.
For the fiscal year ending Feb.
28, 2027, the company expects attributable profit of 32.8 billion yen, basic EPS of 181.24 yen and net sales of 1.092 trillion yen.
Sugi plans to pay interim and year-end dividends of 15 yen and 10 yen per share, respectively, for the current year, which is lower than the total 35 yen per share paid in the year-ago period.